These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 29168983

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Homozygous familial hypercholesterolaemia in Vietnam: Case series, genetics and cascade testing of families.
    Truong TH, Kim NT, Nguyen MNT, Pang J, Hooper AJ, Watts GF, Do DL.
    Atherosclerosis; 2018 Oct; 277():392-398. PubMed ID: 30270076
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Spectrum of mutations in homozygous familial hypercholesterolemia in India, with four novel mutations.
    Setia N, Saxena R, Arora A, Verma IC.
    Atherosclerosis; 2016 Dec; 255():31-36. PubMed ID: 27816806
    [Abstract] [Full Text] [Related]

  • 5. Long-Term Cardiovascular Risk in Heterozygous Familial Hypercholesterolemia Relatives Identified by Cascade Screening.
    Kjærgaard KA, Christiansen MK, Schmidt M, Olsen MS, Jensen HK.
    J Am Heart Assoc; 2017 Jun 26; 6(6):. PubMed ID: 28652386
    [Abstract] [Full Text] [Related]

  • 6. Cascade Screening for Familial Hypercholesterolemia in South Africa: The Wits FIND-FH Program.
    Raal FJ, Bahassi EM, Stevens B, Turner TA, Stein EA.
    Arterioscler Thromb Vasc Biol; 2020 Nov 26; 40(11):2747-2755. PubMed ID: 32878475
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Novel combined variants of LDLR and LDLRAP1 genes causing severe familial hypercholesterolemia.
    Alnouri F, Athar M, Al-Allaf FA, Abduljaleel Z, Taher MM, Bouazzaoui A, Al Ammari D, Karrar H, Albabtain M.
    Atherosclerosis; 2018 Oct 26; 277():425-433. PubMed ID: 30270081
    [Abstract] [Full Text] [Related]

  • 9. Clinical phenotype in relation to the distance-to-index-patient in familial hypercholesterolemia.
    Besseling J, Huijgen R, Martin SS, Hutten BA, Kastelein JJ, Hovingh GK.
    Atherosclerosis; 2016 Mar 26; 246():1-6. PubMed ID: 26745182
    [Abstract] [Full Text] [Related]

  • 10. Value of Measuring Lipoprotein(a) During Cascade Testing for Familial Hypercholesterolemia.
    Ellis KL, Pérez de Isla L, Alonso R, Fuentes F, Watts GF, Mata P.
    J Am Coll Cardiol; 2019 Mar 12; 73(9):1029-1039. PubMed ID: 30846097
    [Abstract] [Full Text] [Related]

  • 11. Health related quality of life in individuals at high risk for familial hypercholesterolemia undergoing genetic cascade screening in Brazil.
    Souto AC, Miname MH, Fukushima J, Jannes CE, Krieger JE, Hagger M, Pereira AC, Santos RD.
    Atherosclerosis; 2018 Oct 12; 277():464-469. PubMed ID: 30270086
    [Abstract] [Full Text] [Related]

  • 12. Independent Severe Cases of Heterozygous Familial Hypercholesterolemia Caused by the W483X and Novel W483G Mutations in the Low-Density Lipoprotein Receptor Gene That Were Clinically Diagnosed as Homozygous Cases.
    Cheng S, Wu Y, Wen W, An M, Gao Y, Wang L, Han X, Shang H.
    Genet Test Mol Biomarkers; 2019 Jun 12; 23(6):401-408. PubMed ID: 31161821
    [Abstract] [Full Text] [Related]

  • 13. A Chinese homozygote of familial hypercholesterolemia: identification of a novel C263R mutation in the LDL receptor gene.
    Wang D, Wu B, Li Y, Heng W, Zhong H, Mu Y, Wang J.
    J Hum Genet; 2001 Jun 12; 46(3):152-4. PubMed ID: 11310584
    [Abstract] [Full Text] [Related]

  • 14. Familial Hypercholesterolemia Phenotype in Chinese Patients Undergoing Coronary Angiography.
    Li JJ, Li S, Zhu CG, Wu NQ, Zhang Y, Guo YL, Gao Y, Li XL, Qing P, Cui CJ, Xu RX, Jiang ZW, Sun J, Liu G, Dong Q.
    Arterioscler Thromb Vasc Biol; 2017 Mar 12; 37(3):570-579. PubMed ID: 27932355
    [Abstract] [Full Text] [Related]

  • 15. Phenotypic variation in heterozygous familial hypercholesterolemia: a comparison of Chinese patients with the same or similar mutations in the LDL receptor gene in China or Canada.
    Pimstone SN, Sun XM, du Souich C, Frohlich JJ, Hayden MR, Soutar AK.
    Arterioscler Thromb Vasc Biol; 1998 Feb 12; 18(2):309-15. PubMed ID: 9484998
    [Abstract] [Full Text] [Related]

  • 16. Low-density lipoprotein levels and not mutation status predict intima-media thickness in familial hypercholesterolemia.
    Fahed AC, Habib RH, Nemer GM, Azar ST, Andary RR, Arabi MT, Moubarak EM, Bitar FF, Haddad FF.
    Ann Vasc Surg; 2014 Feb 12; 28(2):421-6. PubMed ID: 24120234
    [Abstract] [Full Text] [Related]

  • 17. Probabilistic cost-effectiveness analysis of cascade screening for familial hypercholesterolaemia using alternative diagnostic and identification strategies.
    Nherera L, Marks D, Minhas R, Thorogood M, Humphries SE.
    Heart; 2011 Jul 12; 97(14):1175-81. PubMed ID: 21685482
    [Abstract] [Full Text] [Related]

  • 18. Effectiveness of genetic cascade screening for familial hypercholesterolaemia using a centrally co-ordinated clinical service: an Australian experience.
    Bell DA, Pang J, Burrows S, Bates TR, van Bockxmeer FM, Hooper AJ, O'Leary P, Burnett JR, Watts GF.
    Atherosclerosis; 2015 Mar 12; 239(1):93-100. PubMed ID: 25585028
    [Abstract] [Full Text] [Related]

  • 19. Cascade screening and treatment of children with familial hypercholesterolemia in Turkey.
    Kose E, Kose M, Ozturk SI, Ozcan E, Onay H, Ozkan B.
    J Pediatr Endocrinol Metab; 2020 Aug 24; 33(10):1251-1256. PubMed ID: 32829317
    [Abstract] [Full Text] [Related]

  • 20. Cascade screening for familial hypercholesterolemia: Practical consequences.
    Louter L, Defesche J, Roeters van Lennep J.
    Atheroscler Suppl; 2017 Nov 24; 30():77-85. PubMed ID: 29096865
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.